This acquisition reinforces Nexxus' investment strategy in the health and wellness sector. The investment aims to boost SkinClinic's international expansion. The transaction, announced in May, represents the fourth investment by the Nexxus Iberia II fund. SkinClinic, headquartered in Alicante, generates €12 million annually, has 90 employees, and serves 3,000 professional clients in Spain. In addition to direct sales, SkinClinic also offers manufacturing services to third parties.